Search

everythinglearnresearchcommunity

for

Search:↓

Control symptoms and use safe treatments for skin conditions like lichen planopilaris and chronic cutaneous lupus erythematosus.

Hair transplantation and micrografting are effective for facial enhancement with nearly 100% graft survival when done carefully.

Hair transplantation and micrografting are effective for cosmetic facial enhancement, requiring careful technique and postoperative care for successful outcomes.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Antimicrobial therapy can help manage Folliculitis Decalvans.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Laser and light treatments can effectively remove hair long-term.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

A rare genetic skin condition usually affecting males was found in a 9-year-old girl.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.